SEC Form 4 · accession 0001209191-19-016013
TANDEM DIABETES CARE INC · TNDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Morrison
Officer — EVP & CAO
Period of report
Mar 1, 2019
Accepted (ET)
Mar 4, 2019 · 7:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 1, 2019 | M | 50,000 | $2.59 | A | 53,745 | D | |
| Common Stock | Mar 1, 2019 | M | 4,597 | $9.00 | A | 58,342 | D | |
| Common Stock | Mar 1, 2019 | M | 4,121 | $11.059 | A | 62,463 | D | |
| Common Stock | Mar 1, 2019 | M | 1,282 | $11.059 | A | 63,745 | D | |
| Common StockF1 | Mar 1, 2019 | S | 34,646 | $67.35 | D | 29,099 | D | |
| Common StockF2 | Mar 1, 2019 | S | 25,354 | $68.39 | D | 3,745 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF3 | $2.59 | Mar 1, 2019 | M | 50,000 | D | — | Dec 1, 2027 | Common Stock | 50,000 | 30,000 | D |
| Stock OptionF4 | $9.00 | Mar 1, 2019 | M | 4,597 | D | — | May 17, 2027 | Common Stock | 4,597 | 5,903 | D |
| Stock OptionF5 | $11.059 | Mar 1, 2019 | M | 4,121 | D | — | Apr 23, 2023 | Common Stock | 4,121 | 0 | D |
| Stock OptionF5 | $11.059 | Mar 1, 2019 | M | 1,282 | D | — | Apr 23, 2023 | Common Stock | 1,282 | 4,145 | D |
Explanation of responses
- F1The price reported reflects the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2018, in multiple transactions at prices ranging from $67.00 to $67.99.
- F2The price reported reflects the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2018, in multiple transactions at prices ranging from $68.00 to $68.89.
- F3Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter
- F4Twenty five percent (25%) of the underlying shares subject to the option vested on 05/17/2018, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter
- F5The date of the option was 4/23/2013. All shares subject to the option vest in 24 equal monthly installments commencing on 4/23/2013.